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Background: Women account for 23% of newly diagnosed HIV
infections in the United States, but there are few recent, well-
characterized cohorts of U.S. women in whom behavior character-
istics and HIV acquisition have been well-described.
Objective: To evaluate HIV incidence and describe behaviors
among U.S. women residing in areas of high HIV prevalence.
Design: Multisite, longitudinal cohort of women who had HIV
rapid testing and audio computer-assisted self-interviews at baseline
and every 6 months for up to 12 months. (ClinicalTrials.gov:
NCT00995176)
Setting: 10 urban and periurban communities with high HIV prev-
alence and poverty rates, located in the northeastern and south-
eastern United States.
Patients: Venue-based sampling was used to recruit women aged
18 to 44 years who recently had unprotected sex and had 1 or
more additional personal or partner risk factors and no self-reported
previous HIV diagnosis.
Measurements: HIV prevalence and incidence, frequency of HIV
risk behaviors, and health status perceptions.
Results: Among 2099 high-risk women (85.9% black and 11.7%
of Hispanic ethnicity), 32 (1.5%) were diagnosed with HIV infec-
tion at enrollment. Annual HIV incidence was 0.32% (95% CI,
0.14% to 0.74%). Older age, substance use, and knowing a part-
ner had HIV were associated with HIV prevalence. Ten women
died during the study (0.61% per year).
Limitations: Longitudinal assessment of risk behaviors was limited
to a maximum of 12 months. There were few incident HIV infec-
tions, precluding identification of characteristics predictive of HIV
acquisition.
Conclusion: This study enrolled a cohort of women with HIV
incidence substantially higher than the Centers for Disease Control
and Prevention national estimate in the general population of U.S.
black women. Concerted efforts to improve preventive health care
strategies for HIV and overall health status are needed for similar
populations.
Primary Funding Source: National Institutes of Health.
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The HIV epidemic in the United States is concentratedin subpopulations as defined by geography, poverty in-
dicators, race or ethnicity, and transmission method (1).
Women constitute 23% of newly diagnosed HIV infec-
tions in the United States, most of which are acquired by
heterosexual transmission (2). In 2010, surveillance data
from 46 states found that 64% of newly diagnosed HIV
infections among U.S. women occurred among black
women, although black women constituted only 12% of
the female population (3). Limited information about risk
behaviors and HIV incidence in women, coupled with an
inability to enroll U.S. women at high risk for HIV infec-
tion into research studies with HIV incidence as the end
point, has impeded progress in HIV prevention for this
population (4). To evaluate HIV incidence among U.S.
women living in geographic areas with high rates of pov-
erty and HIV prevalence and to assess factors that may
increase risk for HIV and other health problems, the HIV
Prevention Trials Network (HPTN) conducted study
HPTN 064, the Women’s HIV SeroIncidence Study. The
HPTN, funded by the National Institutes of Health, is a
worldwide collaborative clinical trials network that devel-
ops and tests the safety and efficacy of primarily nonvac-
cine interventions for preventing HIV infection (5). The
study was designed to increase understanding of the risk
for HIV infection among certain populations of U.S.
women and to provide information about risk behaviors.
METHODS
Study Design
The HPTN 064 was a multisite, longitudinal cohort
study. Eligible women were enrolled between May 2009
and July 2010 from 10 urban and periurban communities
in 6 geographic areas of the United States (Atlanta, Geor-
gia; Baltimore, Maryland; New York, New York; Newark,
New Jersey; Raleigh/Durham, North Carolina; and Wash-
ington, DC). The study was approved by institutional re-
view boards at each site and collaborating institutions, and
a certificate of confidentiality was obtained.
Participants received HIV rapid testing and audio
computer-assisted self-interviews at baseline and at
6-month intervals for up to 12 months. The audio
computer-assisted self-interview included questions about
socioeconomic factors, food insecurity, mental health (de-
pression and posttraumatic stress disorder [PTSD]), sexual
behavior, history of sexually transmitted infections, domes-
tic violence, health perceptions, and social support. Many
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questions were derived from previous studies, such as the
National HIV Behavioral Surveillance System surveys. The
Center for Epidemiologic Studies Depression Scale used in
HPTN 064 is a shortened version of the standard 32-item
scale (6) and has been used by DiClemente and colleagues
(7) in young black women. A score of 7 or higher (on an
8-item scale) was indicative of psychological distress or de-
pressive symptoms. The Primary Care PTSD Screen, de-
signed for use in general health care settings, indicated
possible presence of PTSD if 3 or more questions had
positive responses (8).
The protocol was designed to follow one half of the
participants for 6 months and the other half for 12 months
to provide the required person-months of observation, as
assumed in the power calculations. However, during the
study, based on a recommendation by the Scientific Mon-
itoring Committee, we decided to increase total person-
years of follow-up. Therefore, study participants in the
6-month group who had not completed follow-up at the
time the decision was made and met extension criteria were
eligible to continue participation for up to 12 months.
Inclusion Criteria and Definitions
Eligible persons were aged 18 to 44 years, identified
themselves as women (transgender persons were eligible),
reported at least 1 episode of unprotected vaginal or anal
sex with a man in the 6 months before enrollment, and
were willing to have HIV rapid testing and receive results.
We used 2 additional inclusion criteria. The first was the
reporting of 1 or more of the following in the past 6
months (except for incarceration, which could have oc-
curred in the past 5 years): illicit injection or noninjection
drug use (heroin, cocaine, crack cocaine, methamphet-
amine, or prescription drugs apart from those prescribed
by a licensed provider); alcohol dependence (defined as
CAGE [Cut Down, Annoyed, Guilty, and Eye Opener]
score 2) (9); binge-drinking, defined as 4 or more drinks
at a time; incarceration (jail or prison 24 hours); self-
reported history of sexually transmitted infections, such as
gonorrhea, chlamydia, or syphilis; exchange of sex for com-
modities, such as drugs, money, or shelter; or reported
male sexual partner with reported history of either injec-
tion or noninjection drug use, sexually transmitted infec-
tions, HIV diagnosis, history of binge-drinking (5 drinks
at a time), alcohol dependence (CAGE score 2) (9), or
incarceration (jail or prison 24 hours within the past 5
years). The second additional requirement was that persons
reside in census tracts (except the Bronx and Harlem in
New York, where ZIP codes were used) that ranked in the
top 30th percentile of HIV prevalence and with more than
25% of inhabitants living below the U.S. federal poverty
threshold, as defined by the 2008 U.S. Census Bureau
(10). These residential criteria are similar to those used by
the Centers for Disease Control and Prevention–sponsored
NHBS-HET (National HIV Behavioral Surveillance Sys-
tem of heterosexuals) study to define areas with high HIV
burden (11, 12). Exclusion criteria included self-reported
history of previous positive results on an HIV test, current
HIV prevention trial enrollment, current or past participa-
tion in an HIV vaccine trial, or anticipated absence for
more than 2 consecutive months during follow-up.
Participant Recruitment and Retention
Venue-based recruitment using time–space sampling,
a method used successfully in previous studies to obtain
large, diverse samples from hard-to-reach populations (13–
15), was conducted in an effort to sample women who may
not be reached using standard recruitment methods. Spe-
cific venues (or locations) in which young women from the
target census tracts (or ZIP codes) could reasonably be
expected to congregate were identified by several methods,
including focus groups of similarly aged community
women, interviews of knowledgeable community experts
(for example, personnel from previous survey studies, such
as the NHBS-HET) who provided a list of potential loca-
tions frequented by young women, and individual discus-
sions with community members. A list of potential venues
(such as laundromats, street corners, or liquor stores) was
created by each study site. Venues were then evaluated by
study personnel, examining whether the target population
(that is, women likely to meet eligibility criteria) fre-
quented the location and when. Those frequented by few
women between ages 18 and 44 years were eliminated. In
addition, whether the venues were feasible recruitment lo-
cations was assessed; those considered unsafe or physically
inadequate or for which permission (if required) could not
be procured were also eliminated from the final venue list.
A sampling frame of venues for specified periods during
Context
There have been few longitudinal studies of HIV incidence
and prevalence among young women living in U.S. urban
and periurban areas with high poverty indicators.
Contribution
In a venue-based longitudinal study, such women had an
estimated HIV incidence rate of 0.32%, similar to that of
some sub-Saharan countries, and an annual mortality rate
of 0.61%. Deaths were largely due to preventable causes,
including HIV infection. Women reported difficulty obtain-
ing medical care.
Caution
The HIV incidence rate found may actually be an under-
estimate due to behavior change secondary to study
participation.
Implication
Improved programs for HIV testing, disease prevention,
and linkage to general medical care should be offered to
young women in areas with high HIV prevalence.
—The Editors
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the day and evening was constructed. Venues for specified
periods were randomly selected each month from the sam-
pling frame to construct a sampling event calendar. To
minimize selection bias, women present at a designated
venue were systematically approached for prescreening
when they entered a predetermined “recruitment area” (for
example, study staff designated the exact space that a po-
tential participant must enter before she was approached
and asked about possible study participation). Women giv-
ing verbal approval for prescreening were asked a limited
number of eligibility questions in a more private area of the
recruitment venue (for example, outside the direct line of
foot traffic). Women who met eligibility criteria and pro-
vided written consent to participate in the HPTN 064
study were subsequently enrolled in an area that provided
additional privacy (that is, the clinical research site, mobile
van, or private room at the venue). To encourage partici-
pants to return for scheduled follow-up appointments,
study staff contacted participants monthly (usually by
phone) to update contact information, after which a nom-
inal amount of money was remunerated. At each in-person
follow-up visit, participants were compensated for their
time and transportation and provided with free condoms
and counseling on HIV prevention measures.
Retention, calculated at 6 and 12 months, was defined
as the number of persons who completed the required
study visit divided by the total eligible number. Partici-
pants enrolled for 12 months who missed the 6-month
visit were permitted to complete the 12-month visit. Par-
ticipants who tested HIV-positive at enrollment or any
time during the study were retained in the cohort and
referred to HIV care.
Outcomes
The primary outcome of the study was a composite
measure of HIV incidence that included infection acquired
shortly before enrollment (recent infections), acute infec-
tion detected at study entry, and seroconversion that oc-
curred during study follow-up. Acute HIV infection was
detected using a 4th-generation antigen/antibody assay or
an HIV RNA test (16). Recent HIV infection was assessed
at study entry using a multiassay algorithm that included
the HIV-1 subtypes B, E, and D (BED) capture enzyme
immunoassay (which measures the proportion of IgG that
is HIV-specific [17]), an assay that measures the avidity of
anti-HIV antibodies for target antigens (18), CD4 cell
count, and HIV RNA viral load (19). Women with HIV
were characterized as recently infected if they had all of the
following test results: BED capture enzyme immunoassay
less than 1.0 normalized optical density units, avidity index
less than 80%, CD4 count greater than 0.200 109
cells/L, and HIV RNA viral load greater than 400 cop-
ies/mL (16). During follow-up, HIV seroconversion was
assessed using HIV rapid test screening with Western blot
confirmation.
Information about participants’ deaths was ascertained
by research staff. For persons lost to follow-up, the Social
Security index, local obituaries, and other relevant sources
were searched. Mortality rate was calculated by dividing
the total number of deaths by the sum of the follow-up
time for all participants.
Sample Size Assessment
The goal was enrollment of 210 women per partici-
pating site for a sample size of 2100 women. Assuming 5%
HIV prevalence at enrollment and 10% loss to follow-up,
approximately 1350 person-years of follow-up were needed
to estimate the 95% CI for the annual HIV incidence with
a width of 1.5% (assuming that the incidence would be
approximately 2%). We assumed that analysis of infections
acquired shortly before enrollment would yield an addi-
tional 830 person-years of data and, when pooled with the
longitudinal data, would yield a CI with a width of 1.32%
or less.
Statistical Analysis
The decision to pool HIV incidence findings from all
communities was decided a priori. Overall, incidence was
determined by combining results from all 3 methods (re-
cent infections at study entry, acute infections at study
entry, and seroconversion during follow-up) using the total
number of these events as the numerator and the 3 non-
overlapping periods of risk (recent, acute, and longitudi-
nal) as the denominator. A CI for overall incidence was
computed on the log scale using an SE obtained by a
weighted combination of SEs for the incidence from the 3
periods and included adjustment for window period uncer-
tainty where appropriate (20).
Because high-risk behaviors were entry criteria for this
study, sensitivity analyses (Appendix, available at www.
annals.org) were done to determine whether changes in
risk behaviors between baseline and 6 and 12 months
could be explained by regression to the mean.
Generalized linear regression with a log link and bino-
mial errors was used to estimate the relative risk between
prevalent HIV infection and individual covariates. Each
regression used all available nonmissing data for the cova-
riate in the current regression. All analyses were done using
SAS, version 9.2 (SAS Institute, Cary, North Carolina).
Role of the Funding Source
The study was funded by the National Institutes of
Health (specifically, the National Institute of Allergy and
Infectious Diseases, National Institute on Drug Abuse, and
National Institute of Mental Health). The funding source
reviewed the study design but had no role in the conduct
or analysis of the study or in the decision to submit the
manuscript for publication.
RESULTS
The Figure shows screening, recruitment, and reten-
tion data, as well as reasons for study discontinuation. Of
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the 8029 women screened, 3233 (40%) were eligible for
enrollment and 2099 (26%) enrolled between May 2009
and August 2010. Most women who were eligible but did
not enroll either did not return to the clinical research site
for enrollment or could not complete enrollment proce-
dures (for example, unsuccessful phlebotomy). As individ-
ual identifiers could not be attached to eligibility screening
data, differences among the eligible population that en-
rolled versus that which did not are unknown. Most par-
ticipants (73%) reported both individual and partner risk
factors. Eighty-six percent of participants reported 1 or
more individual risk factors, 34% reported 3 or more in-
dividual risk factors, and 87% reported male partner risk
factors.
Four hundred six women completed the study at the
6-month visit before the protocol amendment extending
follow-up was approved. Of the 627 women eligible for
extending follow-up, 87% were successfully contacted and
reconsented for 12-month follow-up. Participant retention
was 93% at 6 months and 94% at 12 months. Twenty-
seven women missed the 6-month visit but completed the
12-month visit. Ten participants died during follow-up
(0.61% per year).
Cohort Characteristics
Approximately 85.9% of participants were black,
6.8% white, 2.6% mixed, and 4.8% “other” race. Hispanic
ethnicity was reported by 11.7% of participants, and the
median age was 29 years (Table 1). Nearly all participants
(97%) were born in the United States. Thirty-seven per-
cent had not completed high school, 36.8% had a high
school diploma, and the remainder had education beyond
high school. Most participants (53.8%) were single, and
44.4% reported an annual household income of less than
$10 000. At baseline, 46.3% of participants reported being
concerned about having sufficient food for themselves and
their families over the past 6 months. Only 6% of partic-
ipants considered themselves to be commercial sex workers;
however, 31% of the 1885 participants who did not re-
ported exchanging sex for goods (such as food, money, or
shelter).
Illicit drug use (excluding cannabis) was reported by
22% of participants in the 6 months preceding study
entry, and 24.1% reported at least weekly binge-
drinking (Table 2).
Various types of abuse were reported by participants:
45.1% reported a history of childhood abuse, and 37%
reported some type of abuse (physical, emotional, or sex-
ual) during the 6 months before study entry. At baseline,
35.6% of participants reported symptoms indicative of
psychological distress or depressive symptoms and 29.3%
screened positive for PTSD.
Table 1. Baseline Characteristics of Participants*
Characteristic Participants
(n  2099)








Less than high school graduation 777 (37.0)
High school graduation 772 (36.8)
Education beyond high school 550 (26.2)
Marital status
Single, separated, divorced, or widowed 1258 (59.9)




$10 000 933 (44.4)
$10 001–$20 000 225 (10.7)
$20 000 197 (9.4)
Unknown 744 (35.5)
Food insecurity




* Values are numbers (percentages) unless otherwise indicated. Percentages may
not sum to 100 due to rounding.









Excluded (n = 4796)
Ineligible: 4342
Unknown eligibility: 454
Discontinued (n = 119)
Death: 7
Withdrawal of consent: 5
Loss to follow-up: 107
Completed 6 mo
(n = 1980)*
Discontinued (n = 49)
Death: 3
Loss to follow-up: 46
Completed 12 mo
(n = 1525)
* 1953 attended the visit and 27 missed the visit but returned at 12 mo.
A total of 406 women completed the study at the 6-mo visit.
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At baseline, the median number of sex partners re-
ported by participants in the previous 6 months was 2
(mean, 4.2), and 38% reported anal sex in the 6 months
before study entry (Table 2). Approximately 41.4% and
44% of participants at baseline reported not knowing the
HIV status of their last partner with whom they had vag-
inal sex and anal sex, respectively. One percent reported
that the partner with whom they last had vaginal or anal
sex had HIV. Condom use was infrequent; 18% reported
use at last vaginal or anal sex.
Risky behaviors decreased during follow-up: Condom
use at last vaginal sex increased from 18% at baseline to
35% at 6 months and 37% at 12 months. Sensitivity anal-
yses suggest that 40% to 70% of the increase in condom
use was a study effect.
HIV Infections
Thirty-eight women were newly identified as having
HIV during the study. Thirty-two women (1.5%) had new
diagnoses of HIV at study entry (confirmed by a Western
blot test). Two of the 32 women were identified as having
recently acquired HIV. Two additional women who had
nonreactive HIV rapid test results had acute infection at
study entry. Four women who were not infected at study
entry became infected during follow-up (documented by
HIV seroconversion). The overall annual HIV incidence
for this cohort was 0.32% (95% CI, 0.14% to 0.74%).
There were no associations of either participant or
partner characteristics reported at baseline with incident
HIV infection, probably because of the limited number of
incident infections. However, increasing participant age
and substance use (at least weekly use of illicit drugs or
binge-drinking over the past 6 months) were associated
with prevalent HIV infection (Table 3). The only partner
risk factor associated with prevalent HIV infection in par-
ticipants was known HIV infection of the partner (relative
risk, 8.19 [CI, 2.64 to 25.42]).
Perceived Health Status and Death
At baseline, general health status was reported as “ex-
cellent” or “very good” by 46% of participants (Table 4).
Four hundred seventeen women (20%) reported that they
could not obtain needed health care in the 6 months pre-
ceding enrollment; 61% of these women indicated inabil-
ity to afford care as the reason it was not obtainable (Table
4). Ten women died during the study, for an annual mor-
tality rate of 0.61% per year. Causes of death were available
for 5 of the 10 deceased participants and spanned a range
of preventable causes (Table 5). The only individual risk
behavior statistically significantly associated with death was
drug use (at least weekly, excluding cannabis) (P  0.005).
DISCUSSION
To our knowledge, this is the first study to estimate
HIV incidence using a comprehensive approach that in-
cludes a longitudinal incidence assessment based on HIV
seroconversion, detection of recently acquired HIV at
Table 2. Reported Participant and Partner Characteristics at Baseline*
Characteristic Participants† Missing Responses, %
Participant
Median number of partners in previous 6 mo (IQR) 2 (1–3) 1
Exchange sex for commodities 776 (37.3) 1
HIV status of man with whom had last vaginal sex unknown 865 (41.4) 1
Condom used at last vaginal sex 376 (18.0) 1
Anal sex 796 (38.0) 1
Condom used at last anal sex 143 (18.0) 2
Concurrency‡ 776 (37.1) 1
Self-reported STI (gonorrhea, syphilis, or chlamydia) 232 (11.1) 1.6
At least weekly substance use (including drug use or binge-drinking [4 drinks on 1 occasion]) 782 (37.8) 1.5
At least weekly binge-drinking (4 drinks on 1 occasion) 498 (24.1) 1.5
At least weekly drug use (excluding cannabis) 459 (22.0) 1
Depressive symptoms (CES-D score 7) 692 (35.6) 7.5
PTSD (positive responses to 3 items on the Primary Care PTSD Screen) 600 (29.3) 2.5
Any history of abuse 768 (37.0) 1
Any childhood abuse 934 (45.1) 1
Partner
HIV seropositive diagnosis 28 (1.3) 1
Reported STI (gonorrhea, syphilis, or chlamydia) 215 (10.2) 1
Illicit drug use (injection or noninjection, excluding cannabis) 752 (35.8) 1
Binge-drinking (5 drinks on 1 occasion) 1179 (56.2) 1
Alcohol dependence (CAGE score 2) 869 (41.4) 1
Incarceration within previous 5 y 1233 (58.7) 1
CAGE  Cut Down, Annoyed, Guilty, and Eye Opener; CES-D  Center for Epidemiologic Studies Depression scale; IQR  interquartile range; PTSD  posttraumatic
stress disorder; STI  sexually transmitted infection.
* All characteristics described were within 6 mo of the study start, unless otherwise indicated. Data are based on 2099 participants.
† Values are presented as numbers (percentages) unless otherwise indicated.
‡ Self-report of sex with a man while involved in a sexual relationship with another man during the same period.
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study entry, and detection of acute HIV infection at study
entry. The overall (composite) annual incidence estimate is
0.32%, which is substantially higher than the 2009 na-
tional estimate from the Centers for Disease Control and
Prevention on HIV incidence in the general population of
U.S. black women of similar age (0.05%) (21), suggesting
that the recruitment methods successfully identified
women at risk for HIV. The HIV incidence reported in
this study is similar to that estimated for the general adult
population in some sub-Saharan African countries (Congo,
Table 3. Univariate Analysis of Potential Factors Associated With Prevalent HIV Infection*
Characteristic Prevalence in Women
With HIV at Study
Entry, %
Association With HIV




At least weekly substance use (including drug use or binge-drinking) 60 2.52 (1.22–5.21) 0.013
Concurrency† 40 1.13 (0.55–2.33) 0.85
Education beyond high school (reference: high school graduation or less education) 13.3 0.43 (0.15–1.24) 0.142
Food insecurity 33.3 0.57 (0.27–1.21) 0.148
Anal sex 26.7 0.59 (0.27–1.33) 0.26
At least weekly binge-drinking (4 drinks on 1 occasion) 33.3 1.57 (0.74–3.33) 0.28
At least weekly drug use (excluding cannabis) 43.3 2.71 (1.33–5.53) 0.006
Age 27–33 y (reference: 18–26 y) 23.3 5.83 (1.22–27.96) 0.028
Age 34 y (reference: 18–26 y) 70 11.54 (2.71–49.05) 0.001
Depressive symptoms (CES-D score 7) 44.4 1.45 (0.68–3.07) 0.42
Positive PTSD responses (reference: negative PTSD responses) 21 0.63 (0.26–1.54) 0.41
Any history of emotional, physical, or sexual abuse 20 0.43 (0.18–1.04) 0.061
History of childhood abuse 43.3 0.93 (0.46–1.91) 0.85
Partner, as reported by female participant
Illicit drug use (injection or noninjection) 46.7 1.57 (0.77–3.19) 0.25
Incarceration within previous 5 y 46.7 0.61 (0.30–1.25) 0.189
Reported STI (gonorrhea, syphilis, or chlamydia) 10 0.97 (0.30–3.17) 0.96
HIV seropositive diagnosis 10 8.19 (2.64–25.42) 0.007
Binge-drinking (5 drinks on 1 occasion) 70 1.82 (0.84–3.96) 0.140
Alcohol dependence 50 1.42 (0.70–2.88) 0.35
CES-D  Center for Epidemiologic Studies Depression scale; PTSD  posttraumatic stress disorder; RR  relative risk; STI  sexually transmitted infection.
* Data based on 30 participants. All characteristics described were within 6 mo of the study start, unless otherwise indicated.
† Self-report of sex with a man while involved in a sexual relationship with another man during the same period.







General perception of health, n (%)
Excellent 323 (15) 368 (19) 324 (21)
Very good 646 (31) 610 (31) 478 (31)
Good 782 (37) 655 (34) 492 (32)
Fair 318 (15) 283 (14) 208 (14)
Poor 26 (1) 29 (1) 21 (1)
Missing 4 (1) 8 (1) 1 (1)
Needed medical care but could not get it during previous 6 mo, n (%)
Yes 417 (20) 295 (15) 219 (14)
No 1679 (80) 1650 (84) 1304 (86)
Missing 3 (1) 8 (1) 2 (1)
Main reason needed medical care was not received, n (%)
Could not afford care 257 (61) 172 (58) 134 (61)
Did not know where to find care 26 (6) 16 (5) 18 (8)
Could not get an appointment anywhere 34 (8) 30 (10) 23 (11)
None available 15 (4) 10 (3) 6 (3)
Did not think it was necessary 19 (5) 12 (4) 5 (2)
Thought it was necessary, but never tried to get care 38 (9) 21 (7) 9 (4)
Did not know where to find a physician speaking the same language 5 (1) 4 (1) 4 (2)
Other 23 (6) 28 (9) 20 (9)
Missing 0 (0) 2 (1) 0 (0)
* Percentages may not sum to 100 due to rounding.
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0.28% [CI, 0.23% to 0.35%]; Nigeria, 0.38% [CI, 0.33%
to 0.44%]; and Kenya, 0.53% [CI, 0.34% to 0.70%])
(22), underscoring the substantial ongoing HIV transmis-
sion within specific U.S. populations, including women at
risk, as defined in this study.
Venue-based recruitment with time–space sampling
was successful in recruiting women with elevated risk for
HIV infection. Recruitment venues located in high HIV
prevalence areas and selected for the frequency with which
young women were present offered easy access to study
entry for the target population. The systematic procedures
for recruitment may be used in future studies involving
similar populations. It is noteworthy that this study’s
methods were not designed to recruit a representative com-
munity sample, but rather to systematically sample specific
community members (in this case, young women living in
areas of high HIV prevalence).
The overall annual incidence found in this study may
underestimate the actual incidence in this population be-
cause the behavior of women in the study cohort may have
changed in response to participation (because risk reduc-
tion counseling was done at each study visit and free con-
doms were available). Findings from behavioral assess-
ments during the study suggest the likelihood of this effect
on the basis of the demonstrated decrease in sexual risk
behavior, with reported condom use at last vaginal sex in-
creasing from 18% at baseline to 35% at the 6-month visit
to 37% at the 12-month visit. Because unprotected sex was
an enrollment criterion, some of this change may have
been due to regression to the mean; however, sensitivity
analyses suggest that 40% to 70% of the increase in con-
dom use was a study effect. Nonetheless, approximately
two thirds of participants still reported unprotected vaginal
sex at the 6- and 12-month study visits, clearly demonstrat-
ing that further research is needed to minimize HIV risk
among subpopulations similar to this cohort. Financial in-
security was common and may have motivated the ex-
change of sex for basic commodities, which was reported
by nearly one third of participants.
Although self-reported history of HIV infection was
an exclusion criterion, 32 women (1.5%) were newly diag-
nosed with HIV infection at study entry, 2 of whom were
likely to have been recently infected. Finding this many
newly identified infections at study entry was remarkable
because testing guidelines in the United States have recom-
mended opt-out HIV testing in medical settings since
2006, and several study communities (such as Washington,
DC, and the Bronx) had ongoing HIV testing campaigns.
Despite these participants living in high HIV prevalence
areas of the United States, testing programs or the test
results did not effectively reach them. Although known
HIV infection in a sexual partner was strongly associated
with infection in this study, 41.4% and 44% of the women
were unaware of the status of their last vaginal and anal sex
partners, respectively. These findings emphasize the impor-
tance of testing strategies that provide HIV diagnosis op-
portunities and prevention education to populations at
greatest risk, consistent with recommendations of the Na-
tional HIV/AIDS Strategy (23). The importance of partner
characteristics in HIV acquisition has received recent atten-
tion (24). Most HPTN 064 participants (87%) reported
male sex partners with HIV risk factors, suggesting a need
to enhance HIV prevention initiatives among men who
have sex with women. Clearly, clinicians, researchers, pub-
lic health practitioners, and preventive health programs
should be aware of the importance of HIV testing as well
as the heightened risk of female patients whose demo-
graphic characteristics and risk factors are similar to those
of the women in this study.
A prominent finding was the high mortality rate. Ten
participants died during follow-up, resulting in an annual
mortality rate of 0.61% per year, which is considerably
higher than the expected age-adjusted mortality rate of
0.11% per year (25). Causes of death included diabetic
coma, drug overdose, homicide, and HIV or AIDS, all of
which are preventable. However, necessary medical care
was often unavailable as reported by a substantial propor-
tion of the participants (Table 4). One in 5 women in the
study who needed medical care in the previous 6 months
reported that they were not able to obtain care. Most
women (61%) cited financial reasons for lack of access,
highlighting the critical need for reforms that improve ac-
cess for persons living in poverty. However, structural bar-
riers other than financial need also precluded care, as 18%
of women reported not accessing needed care because they
did not know where to find care, could not get an appoint-
ment, or concluded that care was unavailable. Depressive
symptoms and PTSD were very common in this cohort,
suggesting that mental health services are needed. In this
cohort of relatively young women, only 15% characterized
their health as excellent (Table 4). Although reasons un-
derlying perceptions of health are unknown, one is left to
wonder whether those perceptions would improve in a set-
ting of better access to quality care.
Table 5. Recorded Participant Deaths




2 Cardiac arrest 50
3 Unknown 187
4 Unknown 84
5 Diabetic coma 60
6 Unknown 181
7 End-stage AIDS, cryptococcal meningitis (CD4
count at baseline, 0.011  109 cells/L)
304
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The study has several strengths. It included a careful
assessment of participant characteristics and behaviors and
used a novel combination of laboratory methods to assess
HIV incidence. The HPTN 064 used a rigorous approach to
recruit and retain participants representative of U.S. women at
high risk for HIV; study results apply to U.S. women with
risk profiles similar to those enrolled in this study.
In terms of limitations, all studies based on self-
reported sensitive behavioral data, including this one,
are limited by an inherent social desirability bias (26). The
use of audio computer-assisted self-interviews, however,
probably decreased this bias because they have been found
to increase reporting of sensitive behaviors (27, 28). Study
follow-up was limited to 12 months; it is unknown
whether the reported decreases in risk behaviors in this
study are durable beyond that time. Few incident infec-
tions were seen, precluding our ability to identify specific
risk factors associated with incident HIV infection.
In summary, this study successfully used novel recruit-
ment methods to identify U.S. women at increased risk for
HIV. Indeed, 1 in 300 women in this cohort acquired
HIV infection annually, suggesting that concerted efforts
are needed to define effective prevention strategies for sim-
ilar populations. Populations analogous to that constituted
in HPTN 064 should be considered appropriate for future
HIV prevention research and programming. Finally, this
study, conducted in the United States, shows that en-
hanced risk for HIV infection occurs in the setting of in-
creased mortality rates and inability to obtain needed med-
ical care, suggesting that prevention strategies addressing a
broader agenda than just HIV are needed.
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APPENDIX: SENSITIVITY ANALYSIS METHOD
Because high-risk behaviors were entry criteria for this study,
sensitivity analyses were done to determine whether changes in
risk behaviors between baseline, 6 months, and 12 months could
be explained by regression to the mean. For example, 18% of
women reported condom use at last sex at enrollment and this
increased to 35% at 6 months. It can be shown that the propor-





where s is the population mean of the selection criteria (“any
unprotected sex in the last 6 months”; s was varied between 0.65
and 0.80), r is the correlation between “condom use at last sex” at
baseline and 6 months (measured at 0.2), and  is the correlation
between the selection criteria and “condom use at last sex” (esti-
mated as 0.35 based on the correlation between “any unpro-
tected sex in last 6 months with last 3 partners” and “condom use
at last sex”).
Derivation of the equation for predicting what proportion
of observed change in risk behavior can be attributed to regres-
sion to the mean.
A key risk factor is the behavior “condom use at last sex.” In
the Women’s HIV SeroIncidence Study, this increased from
18% at baseline to 35% at 6 months to 37% at 12 months.
However, a key entry criterion for the study was “Unprotected
sex within the last 6 months” (100% at baseline; not measured at
6 and 12 months). Because unprotected sex was an entry crite-
rion, one would expect condom use at last sex to be low at
baseline and naturally increase at later time points, even in the
absence of any intervention or study participation (a phenome-
non known as “regression to the mean”).
The question of interest is, “What proportion of the ob-
served change is due to regression to the mean?”
Define:
m  long-term mean of risk behavior among participants in
absence of an intervention effect
s  long-term mean of selection criteria among participants
in absence of an intervention effect
X  observed mean of risk behavior at baseline among par-
ticipants
Z  observed mean of selection criteria at baseline among
participants
Yo  observed mean of risk behavior at 6 months among
participants
Yp  predicted mean of risk behavior at 6 months among
participants in absence of an intervention effect and let X, Z, Yo,








where r is the correlation between observations on the risk behavior
6 months apart. That is, r captures the regression to the mean effect.
Thus, the proportion of the observed change from baseline to 6








The difference between the observed mean risk behavior at
baseline and the long-term mean for that risk behavior is un-







where  is the correlation between the selection criteria and the





In the current application, Yo  0.35, X  0.18, Z  1, r 
0.2 is the measured correlation between “condom use at last sex”
at baseline and 6 months,  is estimated as 0.35 based on the
correlation between “any unprotected sex in last 6 months with
last 3 partners” and “condom use at last sex,” and s was varied
between 0.65 and 0.80 in sensitivity analyses.
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